Parallel solid-phase synthesis of vitronectin receptor (αvβ3) inhibitors

This publication has 15 references indexed in Scilit:

• Carbon−Carbon Bond Forming Solid-Phase Reactions
  Chemical Reviews, 1999
• A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.
  Journal of Clinical Investigation, 1997
• Solid-phase organic reactions II: A review of the literature Nov 95–Nov 96
  Tetrahedron, 1997
• Solid-phase organic reactions: A review of the recent literature
  Tetrahedron, 1996
• Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
  Cell, 1994
• Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen.
  Proceedings of the National Academy of Sciences, 1994
• Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA*
  Journal of Vascular Surgery, 1994
• Role of the alpha v beta 3 integrin in human melanoma cell invasion.
  Proceedings of the National Academy of Sciences, 1992
• ArgGlyAsp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts*1
  Experimental Cell Research, 1991
• The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor.
  The Journal of cell biology, 1989